Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Lexicon Pharmaceuticals Ownership Summary

Lexicon Pharmaceuticals is owned by 70.54% institutional investors, 1.17% insiders, and 28.29% retail investors. Artal group is the largest institutional shareholder, holding 37.67% of LXRX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.64% of its assets in Lexicon Pharmaceuticals shares.

LXRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lexicon Pharmaceuticals	70.54%	1.17%	28.29%
Sector	Healthcare Stocks	487.91%	11.08%	-398.99%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Artal group	136.18M	37.67%	$100.77M
Fmr	51.97M	14.38%	$38.38M
Siren	38.92M	10.71%	$36.81M
Blackrock	9.89M	4.03%	$16.62M
Vanguard group	9.88M	2.73%	$7.30M
Schonfeld strategic advisors	7.56M	2.09%	$5.58M
Geode capital management	3.52M	0.97%	$2.60M
State street	2.31M	0.94%	$3.89M
Blackrock funding, inc. /de	3.35M	0.92%	$3.17M
Sessa capital im	3.00M	0.83%	$2.84M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Artal group	136.18M	8.59%	$100.77M
Siren	38.92M	1.90%	$36.81M
Monaco asset management sam	531.60K	0.09%	$502.73K
Sessa capital im	3.00M	0.08%	$2.84M
Hennion & walsh asset management	779.21K	0.04%	$1.05M
Schonfeld strategic advisors	7.56M	0.03%	$5.58M
Ikarian capital	176.48K	0.03%	$166.90K
Cvi	20.00K	0.03%	$33.60K
Straight path wealth management	62.67K	0.02%	$59.26K
Scientech research	57.86K	0.01%	$54.72K

Top Buyers

Holder	Shares	% Assets	Change
Schonfeld strategic advisors	7.56M	0.03%	5.68M
Sessa capital im	3.00M	0.08%	3.00M
Blackrock	9.89M	0.00%	2.20M
Fmr	51.97M	0.00%	2.10M
Vanguard group	9.88M	0.00%	1.79M

Top Sellers

Holder	Shares	% Assets	Change
Orbimed advisors	-	-	-11.02M
Point72 asset management	-	-	-8.99M
Blackrock funding, inc. /de	3.35M	0.00%	-6.66M
Nea management company	-	-	-2.38M
Ameriprise financial	-	-	-2.33M

New Positions

Holder	Shares	% Assets	Change	Value
Sessa capital im	3.00M	0.08%	3.00M	$2.84M
Hrt financial lp	488.47K	0.00%	488.47K	$461.00K
Group one trading	314.40K	0.00%	314.40K	$232.19M
Scientech research	57.86K	0.01%	57.86K	$54.72K
Renaissance	51.14K	0.00%	51.14K	$37.77K

Sold Out

Holder	Change
Newedge advisors	-5.00
Federated hermes	-6.00
Capital performance advisors llp	-18.00
Nelson, van denburg & campbell wealth management group	-21.00
Tortoise investment management	-21.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	126	-3.82%	256,258,970	-3.59%	70	1.31%	59	-11.94%	38	18.75%
Mar 31, 2025	130	-1.52%	265,798,118	-10.70%	73	1.08%	66	-5.71%	33	32.00%
Dec 31, 2024	122	-12.23%	294,769,499	2.13%	81	1.28%	68	-2.86%	20	-4.76%
Sep 30, 2024	138	6.15%	288,617,050	3.46%	79	0.62%	70	-2.78%	21	-8.70%
Jun 30, 2024	130	6.56%	278,967,822	61.45%	113	1.86%	72	9.09%	23	-20.69%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	20.40M	5.64%	2.23M
Fidelity Growth Compy Commingled Pl S	18.09M	4.98%	544.22K
Fidelity Growth Company Fund	12.39M	3.41%	329.91K
Vanguard Total Stock Mkt Idx Inv	5.04M	1.39%	-111.18K
Fidelity Growth Company K6	3.96M	1.09%	168.97K
Vanguard US Total Market Shares ETF	3.89M	1.08%	-
Fidelity Series Growth Company	3.23M	0.89%	108.80K
iShares Russell 2000 ETF	2.88M	0.79%	-
Vanguard Institutional Extnd Mkt Idx Tr	1.99M	0.55%	-908.61K
Columbia Small Cap Value I A	1.91M	0.53%	497.77K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

LXRX Ownership FAQ

Who Owns Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals shareholders are primarily institutional investors at 70.54%, followed by 1.17% insiders and 28.29% retail investors. The average institutional ownership in Lexicon Pharmaceuticals's industry, Biotech Stocks , is 307.10%, which Lexicon Pharmaceuticals falls below.

Who owns the most shares of Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals’s largest shareholders are Artal group (136.18M shares, 37.67%), Fmr (51.97M shares, 14.38%), and Siren (38.92M shares, 10.71%). Together, they hold 62.76% of Lexicon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Lexicon Pharmaceuticals?

Yes, BlackRock owns 4.03% of Lexicon Pharmaceuticals, totaling 9.89M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.62M$. In the last quarter, BlackRock increased its holdings by 2.2M shares, a 28.56% change.

Who is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Artal group is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.59% of its assets in 136.18M Lexicon Pharmaceuticals shares, valued at 100.77M$.

Who is the top mutual fund holder of Lexicon Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Lexicon Pharmaceuticals shares, with 5.64% of its total shares outstanding invested in 20.4M Lexicon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools